CHD9 Polyclonal Antibody BT-AP14941
Specifications
| 20ul / 50ul / 100ul |
Background:
Acts as a transcriptional coactivator for PPARA and possibly other nuclear receptors. Proposed to be a ATP-dependent chromatin remodeling protein. Has DNA-dependent ATPase activity and binds to A/T-rich DNA. Associates with A/T-rich regulatory regions in promoters of genes that participate in the differentiation of progenitors during osteogenesis.,PTM:Phosphorylated on serine and tyrosine residues.,sequence Wrong choice of frame.,Belongs to the SNF2/RAD54 helicase family.,Contains 1 helicase ATP-binding domain.,Contains 1 helicase C-terminal domain.,Contains 2 chromo domains.,subunit:Interacts with PPARA. Probably interacts with ESR1 and NR1I3.,tissue specificity:Widely expressed at low levels. In bone marrow, expression is restricted to osteoprogenitor cells adjacent to mature osteoblasts.,
Classification:
Primary antibody
Alternative names:
Chromodomain-helicase-DNA-binding protein 9 ;CHD-9;EC 3.6.4.12;ATP-dependent helicase CHD9;Chromatin-related mesenchymal modulator;CReMM;Chromatin-remodeling factor CHROM1;Kismet homolog 2
Species reactivity:
Human, Mouse
Host:
Rabbit
Isotype:
IgG
Immunogen:
Synthesized peptide derived from part region of human protein
Concentration:
1 mg/ml
Molecular weight:
Applications:
IHC-p, IF
Storage:
-20°C for 1 year
More info:
Email: info@sobekbio.com
Orders:
Email: orders@sobekbio.com
